B Hero1, T Simon, S Horz, F Berthold. 1. Children's Hospital, University of Cologne, Köln, Germany. barbara.hero@medizin.uni-koeln.de
Abstract
BACKGROUND: The purpose was to investigate the influence of metastatic pattern and primary extension over midline on prognosis of infants with metastatic neuroblastoma. PROCEDURE: Data of 317 consecutive infants with metastatic neuroblastoma were analyzed. RESULTS: The amount of bone marrow infiltration (<10% vs. >10%) proved to be the most important factor and was more important than the presence of bone metastases. A disadvantage in outcome for patients with distant lymph node, intracranial, or atypical metastases or for patients with primary extension over midline could not be demonstrated. However, in the subgroup of patients treated with limited treatment, primary extension over midline proved a risk factor. CONCLUSION: A redefinition of Stage 4S on an international basis is suggested. Copyright 2000 Wiley-Liss, Inc.
BACKGROUND: The purpose was to investigate the influence of metastatic pattern and primary extension over midline on prognosis of infants with metastatic neuroblastoma. PROCEDURE: Data of 317 consecutive infants with metastatic neuroblastoma were analyzed. RESULTS: The amount of bone marrow infiltration (<10% vs. >10%) proved to be the most important factor and was more important than the presence of bone metastases. A disadvantage in outcome for patients with distant lymph node, intracranial, or atypical metastases or for patients with primary extension over midline could not be demonstrated. However, in the subgroup of patients treated with limited treatment, primary extension over midline proved a risk factor. CONCLUSION: A redefinition of Stage 4S on an international basis is suggested. Copyright 2000 Wiley-Liss, Inc.
Authors: Brian H Kushner; Kim Kramer; Shakeel Modak; Timothy J Akhurst; Nai-Kong V Cheung Journal: Pediatr Blood Cancer Date: 2009-12-15 Impact factor: 3.167
Authors: H Ikeda; T Iehara; Y Tsuchida; M Kaneko; J Hata; H Naito; M Iwafuchi; N Ohnuma; H Mugishima; Y Toyoda; M Hamazaki; J Mimaya; S Kondo; K Kawa; A Okada; E Hiyama; S Suita; H Takamatsu Journal: Br J Cancer Date: 2002-04-08 Impact factor: 7.640
Authors: Cinzia Lavarino; Nai-Kong V Cheung; Idoia Garcia; Gema Domenech; Carmen de Torres; Miguel Alaminos; Jose Rios; William L Gerald; Brian Kushner; Mike LaQuaglia; Jaume Mora Journal: BMC Cancer Date: 2009-02-03 Impact factor: 4.430
Authors: G Schleiermacher; H Rubie; O Hartmann; C Bergeron; P Chastagner; F Mechinaud; J Michon Journal: Br J Cancer Date: 2003-08-04 Impact factor: 7.640
Authors: Helen M Ameis; Astrid Drenckhan; Katharina von Loga; Gabriele Escherich; Katharina Wenke; Jakob R Izbicki; Konrad Reinshagen; Stephanie J Gros Journal: PLoS One Date: 2013-12-20 Impact factor: 3.240
Authors: Yousef K Al-Mutawa; Anne Herrmann; Catriona Corbishley; Paul D Losty; Marie Phelan; Violaine Sée Journal: Biosci Rep Date: 2018-08-29 Impact factor: 3.840